Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy, including Merck & Co. The US regulator cleared BMS' LAG-3 drug relatlimab as a ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Godrej 1.5 Ton 3 Star Inverter Split AC (EI 18AINV3R32 PYQ IVBL IOT) price in India starts from ₹ 33,990. The lowest price of Godrej 1.5 Ton 3 Star Inverter Split AC (EI 18AINV3R32 PYQ IVBL IOT) is ₹ ...